ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,780 | -3.7% | 2,157 | 0.0% | 0.06% | -4.5% |
| Q2 2023 | $273,853 | -2.2% | 2,157 | 0.0% | 0.07% | -9.5% |
| Q1 2023 | $279,914 | -1.2% | 2,157 | 0.0% | 0.07% | -15.9% |
| Q4 2022 | $283,193 | +2.6% | 2,157 | -4.4% | 0.09% | +2.3% |
| Q3 2022 | $276,000 | +4.2% | 2,257 | 0.0% | 0.09% | +4.9% |
| Q2 2022 | $265,000 | -9.9% | 2,257 | 0.0% | 0.08% | +10.8% |
| Q1 2022 | $294,000 | -10.4% | 2,257 | +4.9% | 0.07% | -1.3% |
| Q4 2021 | $328,000 | -6.8% | 2,152 | -1.1% | 0.08% | -12.8% |
| Q3 2021 | $352,000 | +4.5% | 2,177 | +5.8% | 0.09% | +7.5% |
| Q2 2021 | $337,000 | +8.7% | 2,057 | 0.0% | 0.08% | -2.4% |
| Q1 2021 | $310,000 | +24.0% | 2,057 | +24.4% | 0.08% | +3.8% |
| Q4 2020 | $250,000 | +8.2% | 1,653 | -2.9% | 0.08% | -6.0% |
| Q3 2020 | $231,000 | -1.3% | 1,703 | 0.0% | 0.08% | -4.5% |
| Q2 2020 | $234,000 | +2.6% | 1,703 | -18.6% | 0.09% | -15.4% |
| Q2 2019 | $228,000 | +4.1% | 2,093 | +7.1% | 0.10% | -1.0% |
| Q1 2019 | $219,000 | – | 1,955 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |